Ana I Salazar-Puerta, María A Rincon-Benavides, Tatiana Z Cuellar-Gaviria, Julian Aldana, Gabriela Vasquez Martinez, Lilibeth Ortega-Pineda, Devleena Das, Daniel Dodd, Charles A Spencer, Binbin Deng, David W McComb, Joshua A Englert, Samir Ghadiali, Diana Zepeda-Orozco, Loren E Wold, Daniel Gallego-Perez, Natalia Higuita-Castro
Acute respiratory distress syndrome (ARDS) represents a significant burden to the health care system, with approximately 200,000 cases diagnosed annually in the US. ARDS patients suffer from severe refractory hypoxemia, alveolar-capillary barrier dysfunction, impaired surfactant function, and abnormal upregulation of inflammatory pathways that lead to intensive care unit admission, prolonged hospitalization, and increased disability-adjusted life years. Currently, there is no cure or FDA-approved therapy for ARDS...
April 29, 2023: Advanced Materials